[Form 4] HELIOS TECHNOLOGIES, INC. Insider Trading Activity
Britt Douglas, a Director of Helios Technologies, Inc. (HLIO), reported an acquisition on 09/18/2025 of 787 Restricted Stock Units (RSUs). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs were reported as acquired at a $0 price and are listed as directly beneficially owned by the reporting person following the transaction (787 shares). The RSUs have a stated vesting/exercisable date of 09/18/2026 and no expiration upon vesting. The Form 4 was signed on behalf of Britt Douglas by Marc Greenberg, Attorney-in-Fact, dated 09/19/2025.
- Transparent disclosure of a director equity award with full details: quantity, vesting date, price, and ownership form
- Equity alignment: 787 RSUs convert one-for-one to common stock, aligning director compensation with shareholders
- Clear documentation including attorney-in-fact signature and filing dates
- None.
Insights
TL;DR: Routine director equity award disclosed; aligns director compensation with shareholder interests.
The Form 4 documents a standard equity grant to a director: 787 RSUs that convert one-for-one into common shares upon vesting on 09/18/2026 at no purchase price. This type of award is commonly used to retain and align directors with long-term shareholder value. The filing is complete in identifying the instrument, quantity, vesting date, ownership form (direct) and the reporting relationship (Director). There are no additional material transactions, liabilities, or derivative instruments disclosed that would complicate governance implications.
TL;DR: Disclosure reports a non-cash equity grant; immaterial to capital structure at reported size.
The submission shows acquisition of 787 RSUs at $0 with direct ownership reported post-transaction as 787 shares, exercisable/vestable 09/18/2026. The Form 4 provides clear mechanics (one RSU equals one share on vesting) and includes an attorney-in-fact signature dated 09/19/2025. Absent other holdings or larger transactions in this filing, this appears to be a routine compensation-related grant rather than a market-moving event based on the information provided.